Instituto de Microcirugía Ocular

What Instituto de Microcirugía Ocular does

Instituto de Microcirugía Ocular (operating as IMO Grupo Miranza) is a Barcelona-headquartered network of ophthalmology clinics providing diagnosis, medical treatment, and surgery across the full ophthalmic subspecialty spectrum, including cornea, cataract, refractive surgery, retina and vitreous, glaucoma, pediatric ophthalmology, oculoplastics, ocular surface, neuro-ophthalmology, and genetic diagnostics. Founded in the mid-1980s, the group operates four physical sites in Barcelona (flagship, with 200+ parking spaces and the group's molecular biology laboratory), Madrid (opened 2020), Manresa (opened 2020, operated via Instituto Oftalmológico Làser Visió S.L.U.), and Andorra la Vella (opened 2022, via Miranza Pirineos S.A.U.). The clinic combines a referral complex-case model with a high-volume refractive and cataract practice, performing roughly 200 corneal transplants per year (approximately 70% selective/lamellar) and using femtosecond-laser technology for refractive surgery through small-incision ReLEx SMILE.

Clinically, IMO differentiates through technology and subspecialist talent. Surgical capability is built on femtosecond and excimer lasers for refractive and cataract work, selective/lamellar corneal transplantation techniques (DMEK and related procedures), and corneal crosslinking with documented keratoconus halt rates around 95%. The in-house molecular biology and genetics laboratory, plus an AEMPS-accredited Ethics Committee for Research with Medicines (CEIm), support sponsored clinical studies and translational research into therapies for currently incurable ocular diseases. The medical team includes co-founder Dr. José Luis Güell (cornea and refractive surgery, 700+ publications) and Dr. María Teresa Iradier (2013 American Academy of Ophthalmology Achievement Award), enabling the clinic to position itself as an international reference center for combined and high-complexity ophthalmic procedures.

Commercially, IMO operates a direct-to-consumer model, accepting patients through online appointment booking, telephone, teleconsultation, and a 24/7/365 emergency ophthalmology service, complemented by partnerships with Spanish health insurers (mutuas), patient financing for non-covered procedures, and an IMO Club loyalty program. Since 2019 the group has been a member of Grupo Miranza, a Spanish network of eye-wellness excellence centers, sharing branding and digital infrastructure (miranza.es). Revenue is generated almost entirely from professional services: consultations, diagnostic tests, surgical procedures (refractive, cataract, corneal transplant, oculoplastic), with premium cataract and refractive tiers; ancillary income derives from financing, emergency services, teleconsultation, and clinical-research activity. The group consists of three Spanish/Andorran legal entities and employs between 51 and 100 staff.

Name

Instituto de Microcirugía Ocular

Legal name

INSTITUTO DE MICROCIRUGÍA OCULAR DOS, S.L.U.

Website

https://imo.es

Company type

Private

Founded year

1985

Operating status

Operating

Headcount range

51–100 employees

Short description

Instituto de Microcirugía Ocular (IMO Grupo Miranza) is a Barcelona-headquartered network of four ophthalmology clinics in Spain and Andorra delivering diagnosis, medical treatment, and surgery across all ophthalmic subspecialties, including cornea, refractive, cataract, retina, glaucoma, and pediatric care, serving individual patients on a direct-to-consumer basis.

Ownership category

akta.pro rank

Product category

Ophthalmology Services

NAICS

Offices of Optometrists (62132), Offices of Optometrists (621320), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Ambulatory Surgery Centers (Ophthalmic/Outpatient Eye Surgery) (HLAKAKAO)

akta.pro secondary industries

Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics) (HLAHAJAH), Contact Lens Specialty & Myopia Control (HLAKAKAK)

Keywords

• Ophthalmology clinic services
• Refractive laser surgery
• Cataract surgery
• Corneal transplantation
• Pediatric ophthalmology

Headquarters

HQ city

Barcelona

HQ country

Spain

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Ophthalmology Consultations and Medical Services: Direct patient consultations across multiple specialties including cornea, retina, glaucoma, pediatric ophthalmology, and oculoplastics. Services include diagnostic tests, medical treatments, and surgical procedures.
2. Surgical Procedures: Revenue from refractive surgery (laser and intraocular lenses), cataract surgery, corneal transplants, and complex combined ophthalmological procedures. Premium services include Premium cataract surgery.
3. Diagnostic Testing: Ophthalmological diagnostic tests including corneal topography, ocular response analysis, and specialized examinations for pre-surgical evaluation.
4. Financing Services: Patient financing options for treatments and surgeries, allowing payment installments for procedures not covered by insurance.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Instituto de Microcirugía Ocular (IMO) is a Spanish ophthalmology clinic chain that provides comprehensive eye care, including diagnosis, medical treatment, and surgical interventions across subspecialties such as cornea, cataract, refractive surgery, retina, glaucoma, pediatric ophthalmology, and oculoplastics. Founded in 1985 in Barcelona, the group operates four centers in Barcelona, Madrid, Andorra, and Manresa, and complements its clinical practice with an in-house molecular biology and genetics laboratory, teleconsultation, and 24-hour emergency services.

Product overview

IMO Grupo Miranza is a network of ophthalmology clinics operating across Spain (Barcelona, Madrid, Manresa) and Andorra, providing comprehensive eye care services. The offering is organized as a multi-location clinic network with specialized departments including cornea, cataract, refractive surgery, retina, glaucoma, pediatric ophthalmology, oculoplastics, and dry eye treatment. The organization operates proprietary diagnostic facilities (corneal topography), surgical theatres, and a molecular biology laboratory for research. Key treatments include laser refractive surgery (LASIK, Relex SMILE), corneal crosslinking, intrastromal rings, and corneal transplantation. Additional services include 24-hour emergencies, teleconsultation, and a patient loyalty program. The clinic chain is part of Grupo Miranza, a leader in eye health excellence centers.

Differentiator

Problem solved

Functional benefit

Products and services

• Refractive Surgery

Quantifiable outcome

• Corneal crosslinking successfully halts keratoconus progression in 95% of treated patients
• +4 more outcomes

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Teatro RealminorGTM or Marketing PartnerIMO Grupo Miranza Madrid has established a partnership with Teatro Real (Royal Theater) to promote eye health and wellness to theater members. The agreement offers Teatro Real members and visitors a 10% discount on first visits, reviews, diagnostic tests, and both surgical and non-surgical treatments. This partnership aims to combine cultural engagement with health awareness, leveraging the theater's membership base to reach potential patients seeking ophthalmological services.

Scale indicators7 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Admiravisión: Admiravisión is a Spain-based ophthalmology and refractive surgery group with a multi-site clinic model targeting similar patient segments to IMO (refractive surgery, cataract, general ophthalmology). It is a comparable direct competitor in the Spanish outpatient eye-care market.
• Clínica Baviera: Clínica Baviera is the largest ophthalmology clinic chain in Spain and Europe, operating dozens of clinics across Spain, Germany, Austria, and Italy with a similar focus on refractive surgery, cataract, and other ophthalmic subspecialties. It is the most direct comparable to IMO in business model, patient profile, and Spanish market positioning.
• Vissum (Grupo Miranza): Vissum is a Spanish ophthalmology chain owned by the same parent, Grupo Miranza, with multiple sites focused on refractive surgery and general ophthalmology. As an intra-group peer, it competes with IMO in some markets and shares capital, branding, and management infrastructure.
• Centro de Oftalmología Barraquer: Barraquer is a long-established ophthalmology center in Barcelona offering comprehensive subspecialty services including cornea, refractive, cataract, retina, and oculoplastics, with a strong research and teaching tradition. It competes head-to-head with IMO for premium complex ophthalmology cases in the Barcelona catchment.

Others

• Alcon: Alcon is a global leader in ophthalmic medical devices and pharmaceuticals, supplying IOLs, refractive surgery lasers, and surgical equipment that IMO uses in cataract and refractive procedures. While not a direct competitor, Alcon shapes the technology and pricing environment in which IMO operates.
• Carl Zeiss Meditec: Carl Zeiss Meditec manufactures ophthalmic diagnostic and surgical equipment, including lasers used in refractive surgery and optical coherence tomography systems used in diagnostics at IMO. It is an enabling supplier rather than a competitor, but influential on technology roadmaps in IMO's clinical areas.

Broad incumbents

• Moorfields Eye Hospital NHS Foundation Trust: Moorfields is one of the world's oldest and largest specialist ophthalmology hospitals, an international reference center for complex eye disease, research, and teaching. It is comparable to IMO as a benchmark for the international reference center positioning and as a potential competitor for cross-border complex cases.

Emerging players

• Hospital Universitario Virgen del Rocío (Ophthalmology Dept.): The ophthalmology department of this major Spanish public teaching hospital performs complex ocular surgery and is a recognized training and research site. It overlaps with IMO in high-complexity procedures but operates under a public funding model rather than a private-pay clinic model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/imogrupomiranza
• YouTubeyoutube.com/channel/UCpX8lg6B9eZ5bLqE6XbXjWA
• Facebookfacebook.com/imogrupomiranza
• LinkedInlinkedin.com/company/imo-grupo-miranza
• Instagraminstagram.com/imo_miranza

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto de Microcirugía Ocular